Mr Ronald Paul Meagher, MD in Edmonds, WA - Anesthesiology

Mr Ronald Paul Meagher, MD is a Anesthesiology physician based in Edmonds, Washington. Mr Ronald Paul Meagher is licensed to practice in Washington (license number MD00008344) and his current practice location is 7305 173rd St Sw, Edmonds, Washington. He can be reached at his office (for appointments etc.) via phone at (425) 743-9429.

NPI number for Mr Ronald Paul Meagher is 1689087967 and his current mailing address is 7305 173rd St S.w, Edmonds, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1689087967.

Contact Information

	Mr Ronald Paul Meagher, MD
	7305 173rd St Sw, Edmonds, WA 98026
	(425) 743-9429
	Not Available

Physician's Profile

Full Name	Mr Ronald Paul Meagher
Gender	Male
Speciality	Anesthesiology
Location	7305 173rd St Sw, Edmonds, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1689087967
Provider Enumeration Date: 06/04/2014
Last Update Date: 06/04/2014

Medical Identifiers

Medical identifiers for Mr Ronald Paul Meagher such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689087967	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	MD00008344 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Ronald Paul Meagher is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Ronald Paul Meagher, MD 7305 173rd St S.w, Edmonds, WA 98026 Ph: (425) 743-9429	Mr Ronald Paul Meagher, MD 7305 173rd St Sw, Edmonds, WA 98026 Ph: (425) 743-9429

News Archive

Discovery of novel SARS-related coronaviruses in bats

In a recent study published on the bioRxiv* server, Peng Zhou, Zheng-Li Shi and colleagues at the Wuhan Institute of Virology, with collaboration from scientists at the University of Chinese Academy of Sciences in China, have identified a new lineage of SARS-related coronaviruses that utilize bat angiotensin-converting enzyme 2 (ACE2) receptors for cell entry, which is the same receptor used by SARS-CoV-2 to infect host cells.

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the companies have entered into a strategic collaboration for the further clinical development and commercialization of CMX157.

Biovail acquires worldwide rights to Tetrabenazine

Biovail Corporation today announced a wholly owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman (tetrabenazine tablets), and the associated intellectual property rights held by Cambridge Laboratories (Ireland) Ltd and its affiliates.

CHIPRA quality measures will provide an excellent set of metrics to judge quality of children's health care

The Children's Health Insurance Program Reauthorization Act (CHIPRA) legislation required a core set of recommended health care quality measures to be identified for voluntary use by State Medicaid and the Children's Health Insurance Programs (CHIP), which together cover almost 40 million American children and adolescents.

Social disparities in the treatment of cardiovascular diseases

Since the introduction of statins to treat high cholesterol, the decline in lipid levels experienced by the wealthy has been double that experienced by the poor. While statins are highly effective in reducing cholesterol and improving heart health, their use may have contributed to expanding social disparities in the treatment of cardiovascular disease, according to research by Virginia W. Chang, MD, PhD, of the Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania, and Diane S. Lauderdale, PhD, of the University of Chicago, published in the September issue of Journal of Health and Social Behavior.

Anesthesiology Doctors in Edmonds, WA

Babu Rajendran, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 Fax: 206-672-0211
Carolyn G. Miller, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 Fax: 206-672-0211
Brendan Rhodes O'donnell, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 21616 76th W Ave, Suite 209, Edmonds, WA 98026 Phone: 425-774-5163 Fax: 425-744-1705
David Inadomi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 Fax: 206-672-0211
Patrick Cheng-ann Lee, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000
Ms. Jessica Kristine Lee, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000
Teresa Marie Schlesinger, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 21616 76th Ave W, Suite #112, Edmonds, WA 98026 Phone: 425-775-6651 Fax: 425-670-6718

Mr Ronald Paul Meagher, MD - Anesthesiology in Edmonds, WA